Cite
MLA Citation
Gérard Zalcman et al.. “Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.” Lancet, vol. 387, no. 10026, 2016, pp. 1405–1414. http://access.bl.uk/ark:/81055/vdc_100031427169.0x000027